허혈/재관류시 Amiodarone이 허혈 전처치에 의한 심근보호에 미치는 영향 = Inhibiting effect of amiodarone to protective action against ischemia/reperfusion injury induced by ischemic preconditioning

다국어 초록 (Multilingual Abstract)

Background: Ischemic preconditioning (IPC) has protective effects on myocardial ischemia. These effects may be caused by ATP (adenosine triphosphate) sensitive potassium (KATP) channel activation. Amiodarone also has pharmacologic preconditioning effects, especially suppression of reperfusion arrhythmia. The mechanisms of amiodarone effects are different from that of IPC. The aim of this study using the isolated rat working heart was 1) to confirm whether IPC and amiodarone protected against reperfusion injury; and, if so, 2) to example whether combination of IPC and amiodarone demonstrated additive effect or not.
Methods: Isolated rat hearts were stabilized for 30 minutes and were subdivided into four groups. Control group was subjected low-flow ischemia of 5% dextrose water for 30 minutes. IPC group was pretreated with IPC. In Amiodarone group, whole process was same as control group except amiodarone administration during low-flow ischemia. Amiodarone-IPC group, IPC was applied and also administrated amiodarone. Isovolumetric left ventricular end systolic pressure (LVESP), left ventricular end diastolic pressure (LVEDP), dP/dtMAX and heart rate were measured.
Results: Group II showed more recovered LVESP, less developed ventricular stiffness, more preserved coronary effluent flow, earlier termination of arrhythmia and smaller infarct size than Group I. Group III showed preserved LVESP and dP/dtMAX, less developed ventricular stiffness, shortest arrhythmia sustaining time, smallest infarct size among all groups. These myocardial protective effects were abolished in Group IV.
Conclusions: We observed that IPC and amiodarone administration, each has myocardial protective effects against myocardial ischemia, but when they are dealt at the same time, their beneficial effects diminished. (Korean J Anesthesiol 2006; 51: 455～62)

참고문헌 (Reference)

1 Balser J.R, "The rational use of intravenous amiodarone in the perioperative period." 86 : 974-987, 1997

2 Curtis M.J, "The rabbit dual coronary perfusion model: a new method for assessing the pathological relevance of individual products of the ischemic milieu: role of potassium in arrhythmogenesis." 25 : 1010-1022, 1991

3 Birincioglu M, "S-T segment voltage during sequential coronary occlusion is an unreliable marker of preconditioning." 277 : 2435-2441, 1999

4 Curtis M.J, "Reperfusion induced arrhythmias are critically dependent upon occluded zone size: relevance to the mechanism of arrhythmogenesis." 21 : 625-637, 1989

5 Vegh A, "Protective effects of preconditioning of the ischemic myocardium involve cyclo-oxygenase products." 24 : 1020-1023, 1990

6 Lubbe W.F, "Protective action of amiodarone against ventricular fibrillation in the isolated perfused rat heart." 43 : 533-540, 1979

7 Liu G.S, "Protection against infarction afforded by preconditioning is mediated by A1 adenosine receptors in rabbit heart." 84 : 350-356, 1991

8 Vahlhaus C, "Prevention of ischemic preconditioning only by combined inhibition of protein kinase C & protein tyrosine kinase in pigs." 30 : 197-209, 1998

9 Flack J.E. 3rd, "Preconditioning the heart by repeated stunning improves myocardial salvage." 84 : 369-374, 1991

10 Shiki K, "Preconditioning of ischemic myocardium: reperfusion induced arrhythmias." 153 : 1470-1476, 1987

11 Arad M, "Preconditioning in globally ischemic isolated rat hearts: effect on function and metabolic indices of myocardial damage." 28 : 2479-2490, 1996

12 Sharma A, "Possible mechanism of cardioprotective effect of ischaemic preconditioning in isolated rat heart." 41 : 635-640, 2000

13 Higgins A.J, "Oxfenicine diverts rat muscle metabolism from fatty acid to carbohydrate oxidation and protects the ischaemic rat heart." 27 : 963-970, 1980

14 Takach T.J, "Myocardial protective effect of amiodarone in hypertrophied hearts during global ischemia." 41 : 542-546, 1986

15 Okubo S, "Myocardial preconditioning: basic concepts and potential mechanisms." 196 : 3-12, 1999

16 Steenbergen C, "Mechanism of preconditioning. Ionic alterations." 72 : 112-125, 1993

17 Zhu J, "Ischemic preconditioning: antiarrhythmic effects and electrophysiological mechanisms in isolated ventricle." 274 : 66-75, 1998

18 Schott R.J, "Ischemic preconditioning reduces infarct size in swine myocardium." 66 : 1133-1142, 1990

19 Liu Y, "Ischemic preconditioning protects against infarction in rat heart." 263 : 1107-1112, 1992

20 Nakano A, "Ischemic preconditioning from basic mechanisms to clinical applications." 86 : 263-275, 2000

21 Asimakis G.K, "Ischemic preconditioning attenuates acidosis and postischemic dysfunction in isolated rat heart." 263 : 887-894, 1992

22 Rubino A, "Ischaemic preconditioning of the vasculature: an overlooked phenomenon for protecting the heart?" 21 : 225-230, 2000

23 Doenst T, "Insulin improves functional and metabolic recovery of reperfused working rat heart." 67 : 1682-1688, 1999

24 Daut J, "Hypoxic dilation of coronary arteries is mediated by ATP-sensitive potassium channels." 247 : 1341-1344, 1990

25 Marfella R, "Hyperglycemia and QT interval: time for re-evaluation." 14 : 63-65, 2001

26 Moreau D, "Effects of amiodarone on cardiac function and mitochondrial oxidative phosphorylation during ischemia and reperfusion." 194 : 291-300, 1999

27 Hagar J.M, "Effect of preconditioning ischemia on reperfusion arrhythmias after coronary artery occlusion and reperfusion in the rat." 68 : 61-68, 1991

28 Grossman W, "Diastolic pressure-volume relations in the diseased heart." 39 : 148-155, 1980

29 King L.M, "Coronary flow and glucose delivery as determinants of contracture in the ischemic myocardium." 27 : 701-720, 1995

30 Gross G.J, "Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs." 70 : 223-233, 1992

31 Rochetaing A, "Beneficial effects of amiodarone and dronedarone (SR 33589b), when applied during low-flow ischemia, on arrhythmia and functional parameters assessed during reperfusion in isolated rat hearts." 38 : 500-511, 2001

32 Ide T, "Amiodarone protects cardiac myocytes against oxidative injury by its free radical scavenging action." 100 : 690-692, 1999

33 Holmes D.S, "Amiodarone inhibits cardiac ATP-sensitive potassium channels." 11 : 1152-1158, 2000

34 Singh S.N, "Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival trial of antiarrhythmic therapy in congestive heart failure." 333 : 77-82, 1995

35 Grover G.J, "ATP-sensitive potassium channel: a review of their cardioprotective pharmacology." 32 : 677-695, 2000